Skip to content

Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction

Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Pulmonary Artery Pressure During Exercise in Normoxia and at Rest in Hypoxia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00559442
Enrollment
30
Registered
2007-11-16
Start date
2007-06-30
Completion date
2011-07-31
Last updated
2013-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Altitude Pulmonary Edema

Keywords

high altitude pulmonary edema, hypoxic pulmonary vasoconstriction, right ventricular function, hypoxia

Brief summary

It has been shown, that subjects susceptible to high altitude pulmonary edema (HAPE)are characterized by an abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia. This abnormal rise of pulmonary artery pressure has also been observed in about 10 % of otherwise healthy subjects without prior altitude exposure. The aim of the study is to investigate the susceptibility to HAPE in unacclimatized subjects with abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia after rapid ascent to high altitude (4559 m).

Interventions

OTHERAltitude Exposure:

rapid ascent to Margherita Hut (4559 m) within 24 h

Sponsors

Heidelberg University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia * ability to climb Margherita Hut

Exclusion criteria

* Birth at or above 1500 m altitude * any cardiovascular or pulmonary disease * Infection disease * Intake of drugs, in particular Acetazolamide, Nifedipine, corticosteroids or PDE-5-inhibitors. * Pregnancy

Design outcomes

Primary

MeasureTime frame
Frequency of HAPE after rapid ascent to 4559 mduring the 48 h stay at altitude

Secondary

MeasureTime frame
Time course of pulmonary artery pressureduring the 48 h stay at altitude
Assessment of right ventricular function by echocardiographyduring the 48 h stay at altitude

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026